Pirh2, an E3 ligase, regulates the AIP4–p73 regulatory pathway by modulating AIP4 expression and ubiquitination

Author:

Abou Zeinab Rami1,Wu H Helena1,Abuetabh Yasser1,Leng Sarah1,Sergi Consolato2ORCID,Eisenstat David D34,Leng Roger P1ORCID

Affiliation:

1. 370 Heritage Medical Research Center, Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada

2. Department of Laboratory Medicine and Pathology (5B4. 09), University of Alberta, Edmonton, Alberta, Canada

3. Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada

4. Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada

Abstract

Abstract Pirh2 is an E3 ligase belonging to the RING-H2 family and shown to bind, ubiquitinate and downregulate p73 tumor suppressor function without altering p73 protein levels. AIP4, an E3 ligase belonging to the HECT domain family, has been reported to be a negative regulatory protein that promotes p73 ubiquitination and degradation. Herein, we found that Pirh2 is a key regulator of AIP4 that inhibits p73 function. Pirh2 physically interacts with AIP4 and significantly downregulates AIP4 expression. This downregulation is shown to involve the ubiquitination of AIP4 by Pirh2. Importantly, we demonstrated that the ectopic expression of Pirh2 inhibits the AIP4–p73 negative regulatory pathway, which was restored when depleting endogenous Pirh2 utilizing Pirh2-siRNAs. We further observed that Pirh2 decreases AIP4-mediated p73 ubiquitination. At the translational level and specifically regarding p73 cell cycle arrest function, Pirh2 still ensures the arrest of p73-mediated G1 despite AIP4 expression. Our study reveals a novel link between two E3 ligases previously thought to be unrelated in regulating the same effector substrate, p73. These findings open a gateway to explain how E3 ligases differentiate between regulating multiple substrates that may belong to the same family of proteins, as it is the case for the p53 and p73 proteins.

Funder

Natural Sciences and Engineering Research Council of Canada

Women and Children Health Research Institute

Canadian Institutes of Health Research

Alberta Cancer Foundation

University of Alberta

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,General Medicine

Reference48 articles.

1. p53, the cellular gatekeeper for growth and division;Levine;Cell,1997

2. Surfing the p53 network;Vogelstein;Nature,2000

3. p63 and p73: p53 mimics, menace and more;Yang;Nat. Rev. Mol. Cell Biol,2000

4. p73 alternative splicing: exploring a biological role for the C-terminal isoforms;Vikhreva;J. Mol. Biol,2018

5. p63 and p73, the ancestors of p53;Dötsch;Cold Spring Harb. Perspect. Biol,2010

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3